Science Explorer Back to mapMap
Discussion
Institution · Kiel · Germany

German Inflammatory Bowel Diseases Study Group

gisg.euROR OpenAlex
Research works
52
▼ 22% vs 2018-21
Citations
1.1k
22.1 per fractional work
Top-10% rate
11.6%
all institutions 10.0%
Open access
35%
world 40%
International
35%
world 18%
German Inflammatory Bowel Diseases Study Group

Not ranked overall: German Inflammatory Bowel Diseases Study Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does German Inflammatory Bowel Diseases Study Group work in?

In all years, 84% of research at German Inflammatory Bowel Diseases Study Group is in Health Sciences, 8% in Social Sciences. Its largest fields are Medicine (82%), Biochemistry, Genetics and Molecular Biology (4%), Immunology and Microbiology (3%). It does 3.1× the world's share of Health Sciences.

Health Sciences: 44 fractional works · 84.1% of its workMedicine: 43 fractional works · 82.0% of its workPathology and Forensic Medicine: 13 fractional works · 24.3% of its workPulmonary and Respiratory Medicine: 5 fractional works · 10.2% of its workOncology: 5 fractional works · 9.2% of its workGenetics: 4 fractional works · 7.4% of its workNeurology: 3 fractional works · 5.7% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 5.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.8% of its workEmergency Medicine: 1 fractional works · 2.3% of its workSurgery: 1 fractional works · 2.2% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.2% of its workHematology: 1 fractional works · 1.8% of its workPsychiatry and Mental health: 1 fractional works · 1.7% of its workEpidemiology: 1 fractional works · 1.3% of its workUrology: 1 fractional works · 1.3% of its workOtorhinolaryngology: 0 fractional works · 1.0% of its workHepatology: 0 fractional works · 0.9% of its workDermatology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.8% of its workHealth Professions: 1 fractional works · 2.1% of its workGeneral Health Professions: 1 fractional works · 1.5% of its workEmergency Medical Services: 0 fractional works · 0.6% of its workSocial Sciences: 4 fractional works · 7.7% of its workBusiness, Management and Accounting: 1 fractional works · 2.3% of its workAccounting: 1 fractional works · 2.3% of its workArts and Humanities: 1 fractional works · 1.9% of its workArcheology: 1 fractional works · 1.9% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.6% of its workEconomics and Econometrics: 0 fractional works · 1.0% of its workFinance: 0 fractional works · 0.6% of its workPsychology: 1 fractional works · 1.3% of its workClinical Psychology: 1 fractional works · 1.3% of its workSocial Sciences: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workLife Sciences: 4 fractional works · 6.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 4.0% of its workMolecular Biology: 1 fractional works · 2.3% of its workCancer Research: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 2.7% of its workImmunology: 1 fractional works · 2.7% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.1% of its workPhysical Sciences: 1 fractional works · 1.3% of its workPhysics and Astronomy: 0 fractional works · 0.5% of its workRadiation: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.1% of its workALL ITS WORKGermanInflammatory…52fractional works, all years
Life Sciences7%Physical Sciences1%Health Sciences84%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine4382.0%
    2. Health Professions12.1%
    1. Business, Management and Accounting12.3%
    2. Arts and Humanities11.9%
    3. Economics, Econometrics and Finance11.6%
    4. Psychology11.3%
    5. Social Sciences00.6%
    1. Biochemistry, Genetics and Molecular Biology24.0%
    2. Immunology and Microbiology12.7%
    3. Agricultural and Biological Sciences00.2%
    4. Neuroscience00.1%
    1. Physics and Astronomy00.5%
    2. Environmental Science00.3%
    3. Earth and Planetary Sciences00.3%
    4. Materials Science00.1%
    5. Computer Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.25× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.33× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.67× its world share, 0 worksImmunology and Micro…Physics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.35× its world share, 0 worksHealth ProfessionsMedicine: 3.34× its world share, 4 worksMedicineArts and Humanities: 4.91× its world share, 1 worksArts and HumanitiesEconomics, Econometrics and Finance: 1.11× its world share, 0 worksEconomics, Econometr…Psychology: 0.39× its world share, 0 worksPsychologySocial Sciences: 0.19× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Arts and Humanities, 4.9×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Arts and Humanities4.91×1 works
  2. Immunology and Microbiology3.67×0 works
  3. Medicine3.34×4 works
  4. Health Professions1.35×0 works
  5. Biochemistry, Genetics and Molecular Biology1.33×0 works
  6. Economics, Econometrics and Finance1.11×0 works
  7. Psychology0.39×0 works
  8. Agricultural and Biological Sciences0.25×0 works
  9. Social Sciences0.19×0 works
  10. Physics and Astronomy0.03×0 works

What are the most cited papers from German Inflammatory Bowel Diseases Study Group?

The most cited paper from German Inflammatory Bowel Diseases Study Group is "Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia" (Hermann Schulz, 2002), with 206 citations. Next come "Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma" (175) and "Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma" (159).

Most cited papers
#PaperReleasedCitations
1 Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia Hermann Schulz · Blood 12 Jul 2002 206
2 Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma Paul Jan Bröckelmann et al. · JAMA Oncology Open access 30 Apr 2020 175
3 Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma L Boudová, Emina Torlakovic, Jan Delabie et al. · Blood 29 Jul 2003 159
4 Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant Sally Arai, Michelle A. Fanale, Sven deVos et al. · Leukemia & lymphoma/Leukemia and lymphoma 26 Apr 2013 141
5 Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group Dennis Alexander Eichenauer, Indra Thielen, Heinz Haverkamp et al. · Blood 30 Jan 2014 141
All 60 most cited papers, with filters and sorting

Which keywords describe research at German Inflammatory Bowel Diseases Study Group?

By fractional works in all years, weighted toward what it does more of than the world: Rituximab, PET Imaging, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Targeted Therapy and Chemotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Rituximab16▲ 195×3 topics
  2. PET Imaging14▲ 122×2 topics
  3. Lymphoma13▲ 170×3 topics
  4. Classification12▲ 66×1 topic
  5. Molecular Profiling12▲ 201×1 topic
  6. Prognostic Factors6▲ 24×5 topics
  7. Targeted Therapy5▲ 47×5 topics
  8. Chemotherapy5▲ 13×12 topics
  9. Radiotherapy4▲ 19×8 topics
  10. Therapeutic Targets4▲ 30×4 topics
  11. Chronic Lymphocytic Leukemia4▲ 144×1 topic
  12. Genomic Aberrations4▲ 144×1 topic
  13. Treatment Guidelines4▲ 32×2 topics
  14. ALK Inhibitors3▲ 118×1 topic
  15. Clinical Trials3▲ 11×2 topics
  16. EGFR Mutations3▲ 118×1 topic
  17. Prognostic Scoring System3▲ 159×2 topics
  18. Methotrexate3▲ 365×1 topic
  19. Primary CNS Lymphoma3▲ 365×1 topic
  20. Cancer Incidence2▲ 26×2 topics
  21. Breast Cancer2▲ 12×5 topics
  22. Immunosuppression2▲ 28×2 topics
  23. Dosimetry2▲ 34×2 topics
  24. Epstein-Barr Virus2▲ 103×1 topic
  25. Kaposi's Sarcoma2▲ 103×1 topic
  26. Cancer Treatment2▲ 11×2 topics
  27. Metastatic Breast Cancer2▲ 44×2 topics
  28. Radioimmunotherapy1▲ 67×1 topic
  29. Radiopharmaceuticals1▲ 67×1 topic
  30. Corporate Governance1▲ 4.1×2 topics
  31. CDK4/6 Inhibitors1▲ 131×1 topic
  32. Palbociclib1▲ 131×1 topic
  33. Pediatric Oncology1▲ 39×2 topics
  34. Acute Lymphoblastic Leukemia1▲ 55×1 topic
  35. Adaptive Reuse1▲ 68×1 topic
  36. Childhood Cancer1▲ 55×1 topic
  37. Derivatives1▲ 32×1 topic
  38. Hedging1▲ 130×1 topic
  39. Intangible Heritage1▲ 68×1 topic
  40. Survival1▲ 15×3 topics

Which research topics does German Inflammatory Bowel Diseases Study Group publish most on?

By volume in 2022-now: Lymphoma Diagnosis and Treatment, Cultural Heritage Management and Preservation, Lung Cancer Treatments and Mutations and Cancer Immunotherapy and Biomarkers.

Lymphoma Diagnosis and T…1Lymphoma Diagnosis and Treatment: 1 fractional worksCultural Heritage Manage…1Cultural Heritage Management and Preservation: 1 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksHealthcare Policy and Management: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksCAR-T cell therapy research: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksCNS Lymphoma Diagnosis and Treatment: 0 fractional works
Pathology and Forensic MedicineArcheologyPulmonary and Respiratory MedicineOncology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  2. 2 Cultural Heritage Management and Preservation Archeology 1 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
  6. 6 Healthcare Policy and Management Economics and Econometrics 0 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 CAR-T cell therapy research Oncology 0 works
  9. 9 Chronic Lymphocytic Leukemia Research Genetics 0 works
  10. 10 CNS Lymphoma Diagnosis and Treatment Neurology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.7%not open65.3%

World: 40% of research is openly available.

with international co-authors35.0%domestic only65.0%

World: 18% is written across borders.

How has German Inflammatory Bowel Diseases Study Group's research output changed?

Output in 2022-2025 was 22% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is German Inflammatory Bowel Diseases Study Group as a percentage of every work published that year, 0.000051% in 2024.

still counting0.00020%0.00040%German Inflammatory Bowel Diseases Study Group0.000023% in 202519801990200020102020

Fractional works of German Inflammatory Bowel Diseases Study Group over all fractional works that year. How the balance of science has shifted.

Other research institutions in Kiel

All research institutions in Kiel

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about German Inflammatory Bowel Diseases Study Group. Posts are plain text and can be reported.